while we're waiting for the next communication

I thought while everyone is patiently (some not so patiently) waiting for the next release from CBZ we could reflect on what has happened thus far.

Firstly: The Trial detals as they appear in the Aust/NZ trial registry

http://www.anzctr.org.au/trial_view.aspx?ID=82770


then, the release from CBZ

http://www.anzctr.org.au/trial_view.aspx?ID=82770

I personally don't believe that this is anywhere near as bad as the market is suggesting. This is definitely backed up by what Mr Michael Monsour had to say in the ALT release as posted by Matakus.

There is evidence of improvement as dosing increases and several indications in the form of comments in the CBZ release to commentary produced by some independent agents acting on behalf of investors. (I believe these have been posted here in the past) that dosing is likely to be the key to better efficacy at 12 weeks. I think it's unlikely we'll hear more on the 24 week results until the full report comes to market later in the year. Obviously 12 weeks was the primary end point for a reason so i'd be sceptical as to whether the 24 week data will be any different.
Call me an optimist but i think the market 'dump' is unwarranted.